SELECT ADVANCED SOLID TUMORS
Clinical trials for SELECT ADVANCED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new SELECT ADVANCED SOLID TUMORS trials appear
Sign up with your email to follow new studies for SELECT ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on hard-to-treat cancers
Disease control Recruiting nowThis study tests a new treatment called KSQ-004EX for people with advanced solid tumors that have not responded to standard therapies. The treatment uses a patient's own immune cells (tumor infiltrating lymphocytes) that are genetically modified to be more powerful against cancer…
Matched conditions: SELECT ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New antibody drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug called CDR404 in up to 42 adults with advanced solid tumors that have a specific marker (MAGE-A4) and tissue type (HLA-A*02:01). The drug is designed to help the body's immune T-cells find and attack cancer cells. The main goals are to chec…
Matched conditions: SELECT ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: CDR-Life AG • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC